These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26206460)

  • 1. The fat droplet in hepatocellular ballooning and implications for scoring nonalcoholic steatohepatitis therapeutic response.
    Argo CK; Ikura Y; Lackner C; Caldwell SH
    Hepatology; 2016 Mar; 63(3):1056-7. PubMed ID: 26206460
    [No Abstract]   [Full Text] [Related]  

  • 2. Ballooned hepatocytes, undead cells, sonic hedgehog, and vitamin E: therapeutic implications for nonalcoholic steatohepatitis.
    Hirsova P; Gores GJ
    Hepatology; 2015 Jan; 61(1):15-7. PubMed ID: 24975580
    [No Abstract]   [Full Text] [Related]  

  • 3. PNPLA3 rs738409 and TM6SF2 rs58542926 gene variants affect renal disease and function in nonalcoholic fatty liver disease.
    Musso G; Cassader M; Gambino R
    Hepatology; 2015 Aug; 62(2):658-9. PubMed ID: 25482317
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply: To PMID 25251399.
    Romeo S; Dongiovanni P; Petta S; Pihalajamaki J; Valenti L
    Hepatology; 2015 Aug; 62(2):660. PubMed ID: 25482212
    [No Abstract]   [Full Text] [Related]  

  • 5. Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease.
    Dongiovanni P; Petta S; Maglio C; Fracanzani AL; Pipitone R; Mozzi E; Motta BM; Kaminska D; Rametta R; Grimaudo S; Pelusi S; Montalcini T; Alisi A; Maggioni M; Kärjä V; Borén J; Käkelä P; Di Marco V; Xing C; Nobili V; Dallapiccola B; Craxi A; Pihlajamäki J; Fargion S; Sjöström L; Carlsson LM; Romeo S; Valenti L
    Hepatology; 2015 Feb; 61(2):506-14. PubMed ID: 25251399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLI2 as a marker of hedgehog-responsive cells.
    Grzelak CA; Sigglekow ND; McCaughan GW
    Hepatology; 2015 May; 61(5):1770. PubMed ID: 25209117
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply.
    Guy CD; Diehl AM
    Hepatology; 2016 Mar; 63(3):1057-8. PubMed ID: 26206676
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply: To PMID 24849310.
    Guy C; Suzuki A; Abdelmalek M; Burchette J; Diehl AM
    Hepatology; 2015 May; 61(5):1770-1. PubMed ID: 25209009
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis.
    Dongiovanni P; Romeo S; Valenti L
    Biomed Res Int; 2015; 2015():460190. PubMed ID: 26273621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical therapy for nonalcoholic fatty liver disease in children and adolescents.
    Andrews DB; Lavine JE
    Expert Rev Gastroenterol Hepatol; 2012 Feb; 6(1):1-3. PubMed ID: 22149573
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment response in the PIVENS trial is associated with decreased Hedgehog pathway activity.
    Guy CD; Suzuki A; Abdelmalek MF; Burchette JL; Diehl AM;
    Hepatology; 2015 Jan; 61(1):98-107. PubMed ID: 24849310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PNPLA3 p.Ile148Met Variant and Obesity: brothers-in-arms: Comment on: PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
    Krawczyk M; Lammert F
    Surg Obes Relat Dis; 2015; 11(4):894-6. PubMed ID: 25862175
    [No Abstract]   [Full Text] [Related]  

  • 13. The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2.
    Anstee QM; Day CP
    Semin Liver Dis; 2015 Aug; 35(3):270-90. PubMed ID: 26378644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin E for nonalcoholic fatty liver disease.
    Mullin GE
    Nutr Clin Pract; 2011 Oct; 26(5):636-7. PubMed ID: 21947647
    [No Abstract]   [Full Text] [Related]  

  • 15. Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).
    Saeed A; Dullaart RPF; Schreuder TCMA; Blokzijl H; Faber KN
    Nutrients; 2017 Dec; 10(1):. PubMed ID: 29286303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic predisposition in nonalcoholic fatty liver disease.
    Sookoian S; Pirola CJ
    Clin Mol Hepatol; 2017 Mar; 23(1):1-12. PubMed ID: 28268262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of nutrition, gene polymorphism, and gut microbiota in non-alcoholic fatty liver disease.
    Kong L; Lu Y; Zhang S; Nan Y; Qiao L
    Discov Med; 2017 Sep; 24(131):95-106. PubMed ID: 28972878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
    Tai CM; Huang CK; Tu HP; Hwang JC; Chang CY; Yu ML
    Surg Obes Relat Dis; 2015; 11(4):888-94. PubMed ID: 25240529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation.
    Carter D; Dieterich DT; Chang C
    Clin Liver Dis; 2018 Feb; 22(1):213-227. PubMed ID: 29128058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH.
    Amrutkar M; Cansby E; Nuñez-Durán E; Pirazzi C; Ståhlman M; Stenfeldt E; Smith U; Borén J; Mahlapuu M
    FASEB J; 2015 Apr; 29(4):1564-76. PubMed ID: 25609431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.